SCHEMBL13769739

SCHEMBL13769739

COC(=O)c1ccc2c(C3CCCCC3)c(-c3ccc(Cl)c4cc[nH]c34)n(CCCO)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.36
SCN9A Q15858 4/20 0.35
ALDH1A1 P00352 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ATM Q13315 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
KCNH2 Q12809 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CCR2 P41597 1/20 0.33
SCARB1 Q8WTV0 1/20 0.33
DPP4 P27487 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13736530 0.90 SCN9A (0.36) BRD4SCN9AALDH1A1NPSR1HPGD
SCHEMBL13736143 0.88 SCN9A (0.33) BRD4SCN9AALDH1A1NPSR1ATM
SCHEMBL3724713 0.82 PKM (0.37) BRD4SCN9AALDH1A1NPSR1ATM
SCHEMBL769188 0.77 ALDH1A1 (0.40) SCN9AALDH1A1NPSR1ATMSMN1; SMN2
SCHEMBL773870 0.76 SCN9A (0.39) SCN9AALDH1A1NPSR1ATMSMN1; SMN2
SCHEMBL3721352 0.75 PDE4D (0.35) BRD4SCN9AALDH1A1NPSR1ATM
SCHEMBL13734752 0.75 HDAC1 (0.36) SCN9AALDH1A1NPSR1SMN1; SMN2HPGD
SCHEMBL3726576 0.75 SCN9A (0.37) BRD4SCN9AALDH1A1NPSR1HPGD
SCHEMBL771574 0.73 SCN9A (0.37) BRD4SCN9AALDH1A1NPSR1ATM
SCHEMBL4826344 0.72 SCN9A (0.41) SCN9AALDH1A1NPSR1ATMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009086139-A1 CONDENSED PENTACYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF FLAVIVIRIDAE INFECTIONS GENELABS TECHNOLOGIES, INC. (US) 2009-07-09 WO disclosed